2026 NPPES data Neuromusculoskeletal Medicine & OMM Physician NPI 1821102732 DO
Verify on CMS →

DAVID GENTILE, DO

Neuromusculoskeletal Medicine & OMM Physician in ROCKY POINT, New York. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
1K
Medicare Part D claims · 177 beneficiaries · Neuromusculoskeletal Medicine & OMM Physician avg: 1K
Generic prescribing
90%
generic claims · 10% brand-name · higher generic rates reduce patient out-of-pocket costs
What the federal data reveals: DAVID GENTILE, DO is a Neuromusculoskeletal Medicine & OMM Physician ([object Object]) practicing in ROCKY POINT, New York with a Medicare Part D prescribing footprint of 1K claims across 177 beneficiaries — 10% brand-name prescribing .

What stands out: DAVID GENTILE, DO filed 1,265 Medicare Part D claims in 2023 across ROCKY POINT, New York. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

Board-eligible specialty (heuristic — not verified)

DAVID GENTILE, DO practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

DAVID GENTILE, DO at a glance

Quality data not reported

NPI registry status

Active

Issued 08/18/2006

NPI 1821102732

Primary specialty

Neuromusculoskeletal Medicine & OMM Physician

Niche

1,235 US NPIs in this specialty

Medicare Part D claims

1,265 14% vs specialty avg

2023 prescription claims

Specialty avg: 1,107

Specialty distribution in New York

How Neuromusculoskeletal Medicine & OMM Physician compares to other specialties among New York providers

New York providers

Neuromusculoskeletal Medicine & OMM Physician share within New York

1. Neuromusculoskeletal Medicine & OMM Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Neuromusculoskeletal Medicine & OMM Physician share within New York

Specialty board-certification context

Estimated specialty board-certified rate — Neuromusculoskeletal Medicine & OMM Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Neuromusculoskeletal Medicine & OMM Physician ABMS/AOA estimate

Est. board-certified rate (Neuromusculoskeletal Medicine & OMM Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Neuromusculoskeletal Medicine & OMM Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

DAVID GENTILE, DO is a Neuromusculoskeletal Medicine & OMM Physician provider practicing in ROCKY POINT, New York, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: DO. NPI: 1821102732. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

DAVID GENTILE, DO appears in the CMS NPPES registry as a Neuromusculoskeletal Medicine & OMM Physician provider holding DO credentials at 797 ROUTE 25A, ROCKY POINT, NY, 11778, with a listed phone of (631) 821-4200. NPI 1821102732 was issued on 08/18/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what GENTILE most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 1,265 prescription claims written by this provider, covering 177 Medicare beneficiaries and totaling roughly $80K in drug spend, split 10% brand-name and 90% generic by claim count, with an opioid prescribing rate of 4.5%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Neuromusculoskeletal Medicine & OMM Physician is a narrow specialty nationwide, with 1,235 enrolled providers across 51 states and an average of 1,107 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

797 ROUTE 25A
ROCKY POINT, NY 11778

Provider Details

NPI 1821102732
Specialty Neuromusculoskeletal Medicine & OMM Physician
Credentials DO
Gender Male
NPI Issued 08/18/2006

License & disciplinary context — New York NYSBPMC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 — they are NOT specific to DAVID GENTILE, DO. To verify DAVID GENTILE, DO's current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases

NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

DAVID GENTILE, DO — brand share 10.0%
Specialty average (est.)

10% brand-name claims vs 90% generic, on 1,265 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

1,265
Total Claims
$80K
Total Drug Cost
177
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
2,706
Total Day Supply
76,939
Brand vs Generic
10% brand / 90% generic
Brand Drug Cost
$44K
Generic Drug Cost
$35K
Opioid Claims
57 (4.5% rate)
Antibiotic Claims
101

Patient Demographics

Average Patient Age
69.6 years
Avg HCC Risk Score
1.20
Gender Split
64% female / 36% male
Age Distribution
<65: 35, 65-74: 86, 75-84: 45, 85+: 11

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Levothyroxine Sodium
106
Famotidine
65
Gabapentin
50
Doxycycline Hyclate
37
Metformin Hcl Er
Metformin Hcl
34
Metformin Hcl
33
Testosterone Cypionate
29
Lisinopril
24
Atorvastatin Calcium
22
Tramadol Hcl
22

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Neuromusculoskeletal Medicine & OMM Physician Overview

How DAVID GENTILE, DO fits within the Neuromusculoskeletal Medicine & OMM Physician landscape nationally.

1,235
Neuromusculoskeletal Medicine & OMM Physician Providers in US
51
States with Neuromusculoskeletal Medicine & OMM Physician
1,107
Avg Claims per Provider

DAVID GENTILE, DO's 1,265 claims are above the specialty average of 1,107.

Nearby Neuromusculoskeletal Medicine & OMM Physician Providers in New York

Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as GENTILE.

Compare Neuromusculoskeletal Medicine & OMM Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is DAVID GENTILE, DO's specialty?
DAVID GENTILE, DO specializes in Neuromusculoskeletal Medicine & OMM Physician and practices in ROCKY POINT, New York. Credentials: DO.
How much does DAVID GENTILE, DO prescribe under Medicare Part D?
In 2023, DAVID GENTILE, DO wrote 1,265 Medicare Part D claims totaling $80K in drug costs for 177 beneficiaries.
Where is DAVID GENTILE, DO located?
DAVID GENTILE, DO is located at 797 ROUTE 25A, ROCKY POINT, NY, 11778. Phone: (631) 821-4200.
What is DAVID GENTILE, DO's NPI number?
DAVID GENTILE, DO's National Provider Identifier (NPI) is 1821102732, issued on 08/18/2006.
Does DAVID GENTILE, DO prescribe more brand-name or generic drugs?
DAVID GENTILE, DO's prescribing is 10% brand-name and 90% generic drugs by claim count, with $44K in brand drug costs.
Does DAVID GENTILE, DO prescribe opioids?
Yes, DAVID GENTILE, DO had 57 opioid claims in 2023 with an opioid prescribing rate of 4.5%.
How many Neuromusculoskeletal Medicine & OMM Physician providers are there in the US?
There are 1,235 Neuromusculoskeletal Medicine & OMM Physician providers across 51 states in the US. The average Neuromusculoskeletal Medicine & OMM Physician provider writes 1,107 Medicare Part D claims per year.
What drugs does DAVID GENTILE, DO prescribe most often?
Based on 2023 Medicare Part D data, DAVID GENTILE, DO's most frequently prescribed drugs include Levothyroxine Sodium, Famotidine, Gabapentin. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does DAVID GENTILE, DO accept Medicare?
DAVID GENTILE, DO appears in CMS Medicare data with 1,265 Part D claims and 177 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify DAVID GENTILE, DO's credentials?
DAVID GENTILE, DO's NPI is 1821102732 with credentials DO. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology